{"name":"Beijing Tide Pharmaceutical Co., Ltd","slug":"beijing-tide-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"beijingtide.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CPD704 Inhalation Suspension","genericName":"CPD704 Inhalation Suspension","slug":"cpd704-inhalation-suspension","indication":"Other","status":"phase_1"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"TDI01 suspension","genericName":"TDI01 suspension","slug":"tdi01-suspension","indication":"Hypertension","status":"phase_3"}]}],"pipeline":[{"name":"CPD704 Inhalation Suspension","genericName":"CPD704 Inhalation Suspension","slug":"cpd704-inhalation-suspension","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"TDI01 suspension","genericName":"TDI01 suspension","slug":"tdi01-suspension","phase":"phase_3","mechanism":"TDI01 suspension is a medication that targets the renin-angiotensin-aldosterone system (RAAS) to treat hypertension.","indications":["Hypertension"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxQMHpmWjJLend0TkZVUGZocjVGdXdBYVZ0Q3p6dDdYcEdCbGE2YktuZkFzdDU2UmFzNmJfYkxUNHZVSWtJaEJlbkR5VzVvYXpXUXVxTy1wLWE2S3V4Tm5XYjljQVNuUk9GajVNNk9GUXN0cDlwdmNVaDdnRl9nang5WXk2eHhJZU1xMlBDWlNCUm83aHlCdl93dkkxUzA0Zk1OalJFMUlLa25ZUHNHZU9DdFVWS1BXTXRZZzdBZXVPVkVIbjZKc0FLWGdSSWR2UUkwemRyQlhNRDNHUGlqTmJoOGhaQ25sb3Z6S3VGWTZ2YXdYV21sRXh4NlNQS0NKQQ?oc=5","date":"2026-03-24","type":"trial","source":"Barchart.com","summary":"Interstitial Lung Disease Clinical Trial Pipeline Expands as 120+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com","headline":"Interstitial Lung Disease Clinical Trial Pipeline Expands as 120+ Companies Driving Innovation in the Therapeutics | Del","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxNWTdhX1lMbXBKaTFMYWwyOGdBeXRrS2hGNzl0LUIxNUZPc3QwMUxFSC0zbzlYcUthYkxoa01ZR3pFdVBTN3ZCTnFUWDUwelJoVk5WNXNKMF9STFF5VWdZUm5oaWI3bDByZ0VfeG1MN0FXTGN3YUR1ZlQ5UE1qZW0yUU4wekxjaUxXWHF6TzFuNlpNV1ZFT3JrX3BsektmS1FUUHNMYnZ6Yl9XczV6UWtjZ2lybVQxS0tNQUV4bGNwczMzeVZZZnozeXkzMXd4em15YlFIVl9RMVlxdnJSS2twNVgyYVViT3cxakl5cWRmS3BmUQ?oc=5","date":"2025-06-12","type":"pipeline","source":"PR Newswire UK","summary":"4 Emerging Graft versus Host Disease Therapies That Could Change the Treatment Landscape | DelveInsight - PR Newswire UK","headline":"4 Emerging Graft versus Host Disease Therapies That Could Change the Treatment Landscape | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxORExtb1NyM1pDdExFRDlwaUhNMjdoYWpHcU9lNU5pSnRTSllsV09uWDdJVVlvTUxKMEpHenRfc0NwSHlpcUVhWVNuOVByRXJGQllNUHBKTHozNFNJcDRkYm9SYkdxcG1oQkozU3h4SmhnT21EZ2k3ZGd0MjJ0UlZOMDhBR0FLRWIzUEpCb3REN2JFYTZpQVZWQXQxT1UySTJxalJzeG9GYW14cXl0Q1lZWWc3cVM5OWt2SHlIZDJXT1FHdw?oc=5","date":"2025-05-06","type":"trial","source":"BioPharma APAC","summary":"Beijing Tide Begins Phase II Trial of First-in-Class Non-Opioid CPSP Drug TRD205 - BioPharma APAC","headline":"Beijing Tide Begins Phase II Trial of First-in-Class Non-Opioid CPSP Drug TRD205","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxQRUlfSDdBcVFrV0xaQzR1Z21kQU1LRHpsX3VDNm1keFZCVGUyVWRnajhDREJZV0tWT2F0YVA2YTBVTmlSLTZtb0Z5N3lWQVp1ZTNGdEdya2czT1ljck1HQ3dYSmpaay1oSHhsZXlqQndWZFpUbnBaZEthTUx0TVdja0ozTFJ3N1hSUEx5YW5GLXE0WUFLWU04ZTdxU1ZaOGFjYVctYmZlSnJZZjlMZDBTMl9xbGlpZXJKc0dORWtHRmJlVnRoV1labGhIX2Y4U0ZWTFhLTVdON3AtZkNRakJoaVAzeVBtNkFmNmhLVWR5T3hTQTlfQ3I4bDJYaWFxdHB3T3NkazRCZ2I2bmxm?oc=5","date":"2024-09-22","type":"trial","source":"GlobeNewswire","summary":"Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight - GlobeNewswire","headline":"Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE03ZHNDSXl5aHJoM0xqaU5FRXBqMndYQjlHd25PaUN0dmktdjcxN0tPRnZxNnlfMXBWdGRCVGNBaG82MGRNWmJxN1pxXzUydnhzNTdQdXNBSjNEZlVhRGllVkFHRURQTWdkNldtdWVnejN6MEVhR3VIcEtsMkJPQQ?oc=5","date":"2022-03-09","type":"trial","source":"China Daily","summary":"Sino Biopharm announces clinical trials for pneumoconiosis drug - China Daily","headline":"Sino Biopharm announces clinical trials for pneumoconiosis drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxNaUI4MmYxdU1iYW5hb2lRdkxLTkdFUlNXUWktN0JiLTZ1Q3RIUkZpaGFYLVFrNGs2dDQ0d1Y4QVEydXRoeXBMMV9mRmcweVZhQTVBbjVJdVVrcE5laERGRm1lclhrTW9WUktNaUZEY3g4djhOMTlJTGVoTkFROHFNUDZjQVNzUDlZWm5yLXhpT0U5cFYySk50SEFuV29vOWdVNC15THM2aWxHSnpXdHFBNURIVl91dmJIUVlmVG54MDRwZC1wN3QwdFdlU2FUcG8xV2NkWFltUnQ?oc=5","date":"2021-02-23","type":"pipeline","source":"prnewswire.com","summary":"Graviton Enters into Global Licensing Agreement for ROCK2 Inhibitor from Beijing Tide - prnewswire.com","headline":"Graviton Enters into Global Licensing Agreement for ROCK2 Inhibitor from Beijing Tide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxPb2lyUUxzbE1Vamg5UUlrdmd6M29HeFJqSDZjbnZwTXJ3anJBSTBPYXBkR3NyRU4xRXRTOTB0OHNyS1lqcmFNbGowNDYzWV93OHpHaEZNNGpweVprM2xNcVJaWWtYYllRS3dnOUxncjRaNk9CZ2tLblJyaTVMSVg2c0o5S2F6T3Btanh3UmpWdVRndWdSVENGZ0NuREctS1o1VkxLQXVaQXZOcENuSEQxTmJFZlFsZ01LSXFadU8wSzJUZ3Q2LU9pRHMwa1ZkSnEzd3NRMTd0clBOZkFJTFd0ZFBjd0JUd3l4cWlFYXRGQmNxSnRHUWJUX0FtWS1NZw?oc=5","date":"2020-03-16","type":"deal","source":"prnewswire.com","summary":"Beijing Tide Pharmaceutical and Insilico Medicine enter into a strategic partnership agreement for cancer therapy - prnewswire.com","headline":"Beijing Tide Pharmaceutical and Insilico Medicine enter into a strategic partnership agreement for cancer therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPZDhvUGl5aDhzall4dUJ4WHphbWFSYUNlN0lNcVh1OTJOaTVaTTRmSENMcDl3Q05FejNROXNqb2JBX2s2VVVmcjlnSk1VUGlqQU9RZmVoc0hMeXVUMUJLWC1nbndGRHJLOE9pc1ZYXzd3M3ZhMFExaDhCODczRV96ZQ?oc=5","date":"2019-02-28","type":"pipeline","source":"China Daily","summary":"Top 10 richest Chinese women - China Daily","headline":"Top 10 richest Chinese women","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}